{
  "report_rows": [
    {
      "kpi": "Adjusted EPS (fiscal Q3 2026)",
      "prediction": "BEAT",
      "answer": "pred ~$1.35 vs. cons $1.33",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth (fiscal Q3 2026)",
      "prediction": "BEAT",
      "answer": "pred ~6.4% vs. cons 6.0%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic orders growth (fiscal Q3 2026)",
      "prediction": "BEAT",
      "answer": "pred ~18% vs. cons 15%",
      "confidence": "LOW"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$4.95 vs. cons $4.90 (fiscal 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Organic sales growth",
      "prediction": "BETTER",
      "answer": "guide ~6.5% vs. cons 6.0% (fiscal 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Implied adjusted EPS",
      "prediction": "BETTER",
      "answer": "guide ~$1.52 vs. cons $1.49 (fiscal Q4 2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted free-cash-flow conversion",
      "prediction": "UNCHANGED",
      "answer": "guide ~100% vs. cons 100% (fiscal 2026)",
      "confidence": "HIGH"
    }
  ],
  "day1_residual_pct": 2.2,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 3.4,
  "day5_path": "FOLLOW-THROUGH",
  "day5_rationale": "The ~$4.95 fiscal-2026 guide combined with predicted Q3 EPS of ~$1.35 implies roughly $1.52 of Q4 EPS versus consensus near $1.49, supporting modest upward revisions; continued double-digit orders should also lift fiscal-2027 estimates, although the elevated valuation limits the magnitude.",
  "day5_confidence": "MEDIUM"
}